Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma.
Kilickap
Saadettin
S
Arslan
Cagatay
C
Senel
Soner
S
Ataseven
Hilmi
H
D014408:Biomarkers, Tumor / Q000097:blood / Q000378:metabolism; D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D016461:Chemoembolization, Therapeutic; D018450:Disease Progression; D018572:Disease-Free Survival; D006801:Humans; D008113:Liver Neoplasms / Q000097:blood / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D011859:Radiography; D019275:Radiopharmaceuticals / Q000008:administration & dosage; D015996:Survival Rate; D015020:Yttrium Isotopes / Q000008:administration & dosage; D000509:alpha-Fetoproteins / Q000032:analysis*
D014408:Biomarkers, Tumor; D019275:Radiopharmaceuticals; D015020:Yttrium Isotopes; D000509:alpha-Fetoproteins